Form 4: PARKERVISION Director Receives 370,000 Stock Options
Insider Transaction Report
PARKERVISION Inc. Director Paul A. Rosenbaum was granted 370,000 stock options as compensation for his 2026 Board service.
Summary
- Paul A. Rosenbaum, a Director of PARKERVISION INC (PRKR), acquired 370,000 derivative securities in the form of options to purchase common stock.
- The transaction date for this acquisition was January 22, 2026.
- Each option has an exercise price of $0.24 and an expiration date of January 22, 2031.
- These options were awarded as compensation for Mr. Rosenbaum's 2026 Board service.
- The options will vest in two equal bi-annual increments on July 22, 2026, and January 22, 2027.
- Following this transaction, Mr. Rosenbaum beneficially owns 370,000 derivative securities directly.
Sentiment
Score: 6
Explanation: The grant of stock options to a director is a standard compensation practice, aligning the director's interests with shareholder value creation, which is generally viewed as a neutral to slightly positive event.
Positives
- The grant of stock options aligns the director's financial interests with those of the shareholders, incentivizing long-term value creation.
- The options are granted at a specific exercise price, providing a clear benchmark for future performance.
Negatives
- No immediate negatives are apparent from this routine compensation filing.
Risks
- The value of the options is subject to the future market price of PARKERVISION INC's common stock, which may fluctuate.
- The options are subject to a vesting schedule, meaning the director must remain in service for the options to become fully exercisable.
Future Outlook
The options are tied to future board service and will vest in two increments over the next year, indicating a continued commitment from the director to the company's performance.
Industry Context
The grant of stock options to directors is a common practice across industries, serving as a form of long-term incentive compensation to align leadership interests with shareholder returns.
Comparison to Industry Standards
- Without specific details on PARKERVISION's compensation philosophy or peer group benchmarks, a direct comparison to industry standards for director compensation is not feasible based solely on this filing.
- However, equity-based compensation, such as stock options, is a widely accepted component of executive and director remuneration in publicly traded companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of 370,000 stock options to Director Paul A. Rosenbaum as compensation for 2026 Board service. | 01/22/2026 | This action reflects the company's compensation policy for its directors, aiming to align their incentives with long-term shareholder value. |
Related Party Transactions
- The grant of stock options to Director Paul A. Rosenbaum constitutes a related party transaction, as it involves compensation provided by the company to a member of its board.
Stakeholder Impact
- Shareholders: The grant aims to align the director's interests with shareholder value, potentially leading to better long-term performance.
- Director (Paul A. Rosenbaum): Receives equity-based compensation, providing a direct financial incentive tied to the company's stock performance.
Next Steps
- The options will vest in two equal bi-annual increments on July 22, 2026, and January 22, 2027, at which point they will become exercisable.
Key Dates
| Date | Description |
|---|---|
| 01/22/2026 | Date of option grant (transaction date) and date exercisable. |
| 07/22/2026 | First bi-annual vesting increment for the options. |
| 01/22/2027 | Second bi-annual vesting increment for the options. |
| 01/22/2031 | Expiration date of the options. |
| 01/26/2026 | Signature date of the reporting person. |
Keywords
PARKERVISION, PRKR, Stock Options, Form 4, Insider Transaction, Director Compensation, Equity Grant, Paul A. Rosenbaum
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.